Tarsus Pharmaceuticals, Inc. - Common Stock (TARS) stock analysis
TARS · Tarsus Pharmaceuticals, Inc. - Common Stock
Latest recorded price: USD 78.68
Sector and industry: Healthcare · Biotechnology
Fiscal 2025 figures: revenue growth 159.5%, free cash flow margin -4.9%, ROIC -52.5%. The model flags 2 risk signals for this company (1 high severity).